how to avoid desk rejection at Lancet Neurology

Editors at Lancet Neurology are effectively running a fast triage on consequence and credibility.

Direct clinical relevance

The journal favors work that helps neurologists make better treatment, diagnostic, prognostic, or management decisions. A paper can be scientifically impressive and still feel too far from care delivery for this venue.

Durable study design

Neurology papers at this level need more than interesting signals. Editors look for endpoint choice, control strategy, sample quality, ascertainment, and follow-up design that can withstand immediate reviewer pressure.

Breadth of relevance

The paper should matter beyond a narrow disease subgroup, one institution, or one heavily selected cohort. Even highly specialized neurology papers need a convincing broader consequence.

Editorial confidence from the package

The title, abstract, figures, cover letter, and reporting details all matter. If the package feels overstated, under-reported, or imprecise, the desk decision usually gets harsher quickly.

This is why strong neurology papers can still die early here. The editors are not only asking whether the science is respectable. They are asking whether the paper looks like something neurologists across subspecialties should care about now. If the answer feels niche, speculative, or too method-heavy for the practical consequence, the journal often decides quickly.

• Submitting basic science, animal-model, or biomarker work without a clear bridge to clinical neurology.
• Using surrogate endpoints that do not convincingly map to a meaningful patient outcome.
• Presenting an underpowered cohort as if it supports a field-level conclusion.
• Framing a technically solid study as practice-changing when the actual clinical implication is modest.
• Using a single-center or highly selected sample without explaining why the result generalizes.
• Ignoring reporting expectations for trials, observational studies, or systematic reviews.
• Sending a cover letter that summarizes the abstract instead of arguing why the paper belongs in Lancet Neurology rather than JAMA Neurology, Brain, Neurology, or Annals of Neurology.

Another common trigger is a paper that reads as if the authors are still in love with the mechanism but have not fully translated the message for a clinically oriented editor. Lancet Neurology will publish technically serious work, but it still wants the clinical decision consequence to be visible.

Before submission, ask four blunt questions:

1. Would a practicing neurologist know why this matters after reading only the abstract?
2. Are the endpoints strong enough that a skeptical reviewer cannot dismiss the paper as surrogate-heavy?
3. Does the paper still look important if the novelty language is stripped away?
4. Is there a real reason this belongs in Lancet Neurology instead of a slightly narrower journal?

If those answers are shaky, the safest move is to fix the package before you submit.

You can usually tell when a paper is closer to the Lancet Neurology bar because the package behaves differently from the start:

• the title and abstract make the clinical consequence obvious
• the endpoint logic feels defensible without a long explanation
• the figures support a neurologist-facing message, not only a technical one
• the discussion does not need inflated novelty language to sound important
• the cover letter explains why the manuscript belongs here rather than at JAMA Neurology, Brain, Neurology, or Annals of Neurology

That matters because a lot of borderline submissions are not obviously bad. They are simply one step too narrow, one step too surrogate-driven, or one step too local for this editorial tier. The stronger the package is at answering those concerns before review, the lower the desk-rejection risk becomes.

One common mistake is assuming that any strong neurology paper with clinical data is naturally a Lancet Neurology paper. That is not how the journal thinks. Editors usually distinguish between:

• papers that refine specialty understanding
• papers that alter neurological practice or field-level judgment

The first group can still be excellent, but it often belongs somewhere else. The second group is what gets more editorial patience here. If your manuscript mainly improves a subspecialty conversation without broader neurology consequence, that is usually the fit problem you need to solve before submission.

The fastest self-check is this: if a general neurology editor would need extra explanation before seeing why the result changes field-level judgment, the fit is probably still too weak for this journal.

That usually means the paper should either sharpen its practical consequence or move to a journal whose audience is narrower and more specialized.